Our Partnerships

Advancing GEMM™ Research

Melius MicroBiomics Inc. collaborates with the University of British Columbia and Innovate Phytoceuticals Laboratory, leveraging their extensive R&D expertise to enhance our work in GEMM.

University of British Columbia

Patented

MMB and UBC have entered a licensing agreement to commercialize the patented technology related to BioPersist & BioColonize.

R&D

Pre-clinical studies show BioPersist are more effective as frontline IBD drugs. We plan to conduct a series of clinical trials to further evaluate BioPersist in humans and animals.

Innovate

Phytoceuticals

Innovate Phytoceuticals laboratory is integrated with full-spectrum R&D and analytical capabilities including testing, formulation, validation, genomic and metabolic fingerprinting, tissue culture and genetic development, and IP development. In Kelowna, Canada, Melius MicroBiomics Inc. is currently incubated by Innovate Phytoceuticals.